• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

intel

OXOS Medical Raises $23M to Deliver ”Radiology Department in a Box”

by Syed Hamza Sohail 04/05/2023 Leave a Comment

OXOS Medical Raises $23M Series A to Deliver ”Radiology Department in a Box”

What You Should Know: OXOS Medical, the MedTech innovator developing simple and safe X-ray solutions, announced a $23 million Series A funding from Parkway Venture Capital and Intel Capital, bringing its total funding to $45 million.OXOS continues to build on its traction across outpatient clinics, the military, the Veterans Administration, sports teams, hospitals, imaging centers, and bioskills labs. To help accelerate the company’s growth, Gregg Hill, Parkway Venture Capital co-founder and
Read More

Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors

by Syed Hamza Sohail 12/05/2022 Leave a Comment

Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors

What You Should Know: - Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors. - The largest medical federated learning study to date with an unprecedented global dataset examined from 71 institutions across six
Read More

The Gains and Pains of Using AI in the Pharmaceutical Industry

by Michael Galarnyk, AI Evangelist at cnvrg.io 10/25/2022 Leave a Comment

The Gains and Pains of Using AI in the Pharmaceutical Industry

The costs for drug discovery and development are skyrocketing, but AI (artificial intelligence) is introducing new efficiencies to help find effective treatments faster. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million. Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most
Read More

Intel Invests $20M in Biofourmis’ Virtual Care Offerings

by Syed Hamza Sohail 08/10/2022 Leave a Comment

Biofourmis AI Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

What You Should Know: - Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M. - The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More

Intel & Sheba Partner to Develop AI Solution to Improve Detection of Crohn’s Disease

by Syed Hamza Sohail 07/27/2022 Leave a Comment

Sheba Medical Center to Create The First Fully VR-Based Hospital In The World Sheba Medical Center Declares Israel’s “City of Health”, Inks $350M Deal

What You Should Know: - Sheba Medical Centre, Israel’s largest medical center, today announced a collaboration with Intel Corporation to help doctors improve the diagnosis and treatment of people with Crohn's disease. - Sheba developed a new, first-of-its-kind application capable of quickly and accurately analyzing extensive video data of a patient’s digestive system, providing valuable insights to aid medical professionals. AI-driven Solutions to Diagnose Crohn’s Disease The
Read More

BeeKeeperAI Partners with Microsoft to Accelerate AI-Powered Innovation in Healthcare

by Jasmine Pennic 05/25/2022 Leave a Comment

BeeKeeperAI Partners with Microsoft to Accelerate AI-Powered Innovation in Healthcare

What You Should Know: - BeeKeeperAI, a company powering AI-powered solutions that will help to redefine the future of healthcare today announced its expanded collaboration with Microsoft. - The collaboration will allow algorithm developers and healthcare data stewards to access BeeKeeperAI, operating in the Microsoft Azure confidential computing (ACC) environment, through the Azure Marketplace. New Frontier for Healthcare AI Research The enhanced collaboration aims to accelerate the
Read More

Biofourmis Secures $300M to Expand Virtual Care Offerings

by Digital Health Funding 04/26/2022 Leave a Comment

Biofourmis Secures $300M to Expand Virtual Care Offerings

What You Should Know: - Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, - Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman. Transforming Patient Health Through Personalized, Predictive Care Founded in
Read More

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%

by Fred Pennic 04/26/2022 Leave a Comment

DiA Imaging Analysis Partners with Intel to Improve Ultrasound Analysis by 40%

What You Should Know: - DiA Imaging Analysis Ltd, a global provider of AI-powered ultrasound analysis software, has teamed up with Intel to streamline artificial intelligence (AI) solutions used by echocardiography (Echo) labs. - DiA’s AI-based software, LVivo Seamless™, automatically analyzes cardiac ultrasound images using the Intel® Distribution of OpenVINO™ toolkit, to optimize processing time by over 40% percent while maintaining accuracy. Accelerating Processing Times for AI-Based
Read More

VDI: Promising Approach for Healthcare IT to Ease Endpoint Management?

by Emanuel Pirker, Founder and CEO, Stratodesk 04/14/2022 Leave a Comment

VDI – The Cure For What Ails Healthcare IT?

Healthcare IT has always faced unique challenges.  Among these challenges are the increasing mobility of healthcare workers. Healthcare providers are always on the move throughout hospitals. Still, they need to access the same apps and data, and their own unique workspace, wherever they are, quickly and securely.  Additionally, strict legal requirements and internal policies govern exactly how confidential patient data can be stored and accessed. Not to mention the need for
Read More

Intel, Samsung Partner on AI-Based Ultrasound Solution for Anesthesia Administration

by Fred Pennic 03/16/2021 Leave a Comment

Intel, Samsung Partner on AI-Based Ultrasound Solution for Anesthesia Administration

What You Should Know: -  Samsung Medison and Intel are collaborating on NerveTrack™, a real-time nerve tracking ultrasound feature that helps anesthesiologists identify nerves in a patient’s arm to help administer anesthesia quickly and accurately. Leveraging the Intel Distribution of OpenVINO toolkit for computer vision and annotation, Samsung Medison’s NerveTrack™ can reduce scanning time by up to 30 percent in an extremely
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |